Suppr超能文献

肝硬化腹水患者的治疗。

Treatment of patients with cirrhosis and ascites.

作者信息

Runyon B A

机构信息

Transplantation Institute, Loma Linda University Medical Center, CA 92354, USA.

出版信息

Semin Liver Dis. 1997;17(3):249-60. doi: 10.1055/s-2007-1007202.

Abstract

The treatment of patients with cirrhosis and fluid overload has undergone substantial change in recent years, because of new information regarding old treatments, as well as new treatments. The goals of treatment are to maximize life expectancy and quality of life. Development of ascites is a landmark in the natural history of cirrhosis signaling poor life expectancy, in general. Patients who are appropriate candidates for liver transplantation should undergo evaluation for this procedure after development of ascites. Patients awaiting transplantation as well as non-candidates for this procedure should be managed by restriction of dietary sodium and prescription of diuretics. This approach is effective in controlling fluid overload in > 90% of patients. Only the 10% who fail this simple medical treatment should be considered for second-line therapy.

摘要

近年来,由于有关旧疗法的新信息以及新疗法的出现,肝硬化和液体超负荷患者的治疗发生了重大变化。治疗的目标是最大限度地延长预期寿命和提高生活质量。腹水的出现是肝硬化自然病程中的一个里程碑,通常预示着预期寿命不佳。适合肝移植的患者在出现腹水后应接受该手术的评估。等待移植的患者以及不适合该手术的患者应通过限制饮食中的钠摄入和使用利尿剂来进行管理。这种方法在控制超过90%的患者的液体超负荷方面是有效的。只有10%未能通过这种简单药物治疗的患者才应考虑二线治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验